Trinity Biotech plc - Asset Resilience Ratio

Latest as of September 2023: 29.53%

Trinity Biotech plc (TRIB) has an Asset Resilience Ratio of 29.53% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Trinity Biotech plc to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$18.78 Million

Cash + Short-term Investments

Total Assets

$63.60 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (1997–2020)

This chart shows how Trinity Biotech plc's Asset Resilience Ratio has changed over time. See Trinity Biotech plc balance sheet quality to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Trinity Biotech plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see TRIB company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$18.78 Million	29.53%
Total Liquid Assets	$18.78 Million	29.53%

Asset Resilience Insights

Very High Liquidity: Trinity Biotech plc maintains exceptional liquid asset reserves at 29.53% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Trinity Biotech plc Industry Peers by Asset Resilience Ratio

Compare Trinity Biotech plc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%
Polynovo Ltd AU:PNV	Medical Devices	0.04%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Dirui Industrial Co Ltd SHE:300396	Medical Devices	6.89%
Emvision Medical Devices Ltd AU:EMV	Medical Devices	0.06%

Annual Asset Resilience Ratio for Trinity Biotech plc (1997–2020)

The table below shows the annual Asset Resilience Ratio data for Trinity Biotech plc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2020-12-31	0.00%	$0.00	$130.40 Million	--
2019-12-31	0.89%	$1.17 Million	$131.07 Million	-14.60pp
2018-12-31	15.49%	$23.42 Million	$151.24 Million	-2.19pp
2017-12-31	17.67%	$34.04 Million	$192.62 Million	-8.70pp
2015-12-31	26.37%	$94.66 Million	$358.96 Million	+25.60pp
2014-12-31	0.77%	$1.88 Million	$242.84 Million	-5.09pp
2013-12-31	5.86%	$13.28 Million	$226.49 Million	-26.30pp
2012-12-31	32.17%	$63.50 Million	$197.41 Million	-7.43pp
2011-12-31	39.59%	$67.90 Million	$171.50 Million	+5.03pp
2010-12-31	34.56%	$55.60 Million	$160.87 Million	+33.50pp
2009-12-31	1.06%	$1.40 Million	$132.44 Million	-0.49pp
2008-12-31	1.54%	$2.00 Million	$129.51 Million	-0.54pp
2007-12-31	2.08%	$4.50 Million	$215.98 Million	-4.14pp
2006-12-31	6.22%	$15.50 Million	$249.13 Million	+3.53pp
2005-12-31	2.69%	$4.96 Million	$184.60 Million	+2.47pp
1998-12-31	0.22%	$100.00K	$45.00 Million	-5.47pp
1997-12-31	5.69%	$1.40 Million	$24.60 Million	--

pp = percentage points

About Trinity Biotech plc

NASDAQ:TRIB USA Medical Devices

Market Cap

$10.80 Million

Market Cap Rank

#26857 Global

#5510 in USA

Share Price

$0.58

Change (1 day)

+1.74%

52-Week Range

$0.54 - $1.91

All Time High

$67.65